Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane-Reference-Cited by-同舟云学术

Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane

Published:2015 Issue:12 Volume:7 Page:5240-5248
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Bruno Giacomo¹²³⁴⁵,Geninatti Thomas¹²³⁶⁷,Hood R. Lyle¹²³,Fine Daniel¹²³,Scorrano Giovanni¹²³,Schmulen Jeffrey¹²³,Hosali Sharath⁸⁹¹⁰,Ferrari Mauro¹²³,Grattoni Alessandro¹²³

Affiliation:

1. Nanomedicine Department

2. Houston Methodist Research Institute (HMRI)

3. Houston, USA

4. Politecnico di Torino

5. Turin, Italy

6. College of Materials Science and Engineering

7. University of Chinese Academy of Sciences (UCAS)

8. Nanomedical System

9. Inc.

10. Austin, USA

Abstract

General adoption of advanced treatment protocols such as chronotherapy will hinge on progress in drug delivery technologies that provide precise temporal control of therapeutic release.

Funder

National Institutes of Health

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2015/NR/C4NR06209D

Reference51 articles.

1. Chronopharmaceutical drug delivery systems: Hurdles, hype or hope?☆

2. A Circadian Clock Transcription Model for the Personalization of Cancer Chronotherapy

3. Phase I – II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 study